Jeff Golden brings more than 25 years of pharmaceutical industry experience in global regulatory information management and eCTD. He leads Syner-G’s Regulatory Operations team, providing strategic guidance and high-quality electronic publishing services for pharmaceutical and biotech clients.

Under his leadership, the department has supported over 100 biopharmaceutical companies and contributed to successful drug and biologic submissions to the FDA, EMA, Health Canada, and Swiss Medic. Jeff previously held roles at Astellas, TAP Pharmaceuticals, Takeda, and Chimerix, and joined Syner-G through the 2021 acquisition of Impact Pharmaceutical Services.